Ipidacrine (Axamon), A Reversible Cholinesterase Inhibitor, Improves Erectile Function in Male Rats With Diabetes Mellitus-Induced Erectile Dysfunction

ABSTRACTS: Background: Management of diabetes mellitus-induced erectile dysfunction (DMED) is challenging because of its insufficient responses to phosphodiesterase type 5 inhibitors. Aim: To compare the effects of ipidacrine, a reversible cholinesterase inhibitor, and sildenafil on DMED in a rat m...

Full description

Bibliographic Details
Main Authors: Vladimir Bykov, MD, PhD, Evgenia Gushchina, Sergey Morozov, PhD, Natalia Zhuravskaya, Kirill Kryshen, PhD, Valery Makarov, MD, PhD, Aleksandr Matichin, Alena Zueva
Format: Article
Language:English
Published: Oxford University Press 2022-02-01
Series:Sexual Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2050116121001574